Abstract
Our objective for Current Neurovascular Research is to consistently provide a broad platform for leading scientific inquiry of both neuronal and vascular origins in neuroscience. To this end, our current issue is no exception to this rule and offers the opinions and hypotheses of scientific leaders from a broad spectrum of investigative fields. In this issue, the initial article by Lehmann et al. outlines the function of cellular water-selective channels in the central nervous system, termed aquaporins, and the unique role that these channels play in water transport during disorders such as cerebral ischemia, trauma, and neoplasms. Subsequently, the next series of articles in this issue highlight novel therapeutic strategies for a variety of nervous system disorders. Sakamaki presents the molecular mechanisms that can determine vascular endothelial cell injury in conjunction with the cellular and environmental factors that can repair damaged vascular cells and foster new endothelial cell growth during angiogenesis. In another article by Panchal et al., cellular mediators of abnormal
Keywords: Aquaporins, apoptosis, neuropathies
Current Neurovascular Research
Title: From the Editors Perspective: Aquaporins to Apoptosis
Volume: 1 Issue: 4
Author(s): Kenneth Maiese
Affiliation:
Keywords: Aquaporins, apoptosis, neuropathies
Abstract: Our objective for Current Neurovascular Research is to consistently provide a broad platform for leading scientific inquiry of both neuronal and vascular origins in neuroscience. To this end, our current issue is no exception to this rule and offers the opinions and hypotheses of scientific leaders from a broad spectrum of investigative fields. In this issue, the initial article by Lehmann et al. outlines the function of cellular water-selective channels in the central nervous system, termed aquaporins, and the unique role that these channels play in water transport during disorders such as cerebral ischemia, trauma, and neoplasms. Subsequently, the next series of articles in this issue highlight novel therapeutic strategies for a variety of nervous system disorders. Sakamaki presents the molecular mechanisms that can determine vascular endothelial cell injury in conjunction with the cellular and environmental factors that can repair damaged vascular cells and foster new endothelial cell growth during angiogenesis. In another article by Panchal et al., cellular mediators of abnormal
Export Options
About this article
Cite this article as:
Maiese Kenneth, From the Editors Perspective: Aquaporins to Apoptosis, Current Neurovascular Research 2004; 1 (4) . https://dx.doi.org/10.2174/1567202043362054
DOI https://dx.doi.org/10.2174/1567202043362054 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Serotonin 5-HT<sub>4</sub> Receptors: A New Strategy for Developing Fast Acting Antidepressants?
Current Pharmaceutical Design Brain Slices as Models for Neurodegenerative Disease and Screening Platforms to Identify Novel Therapeutics
Current Neuropharmacology Advances in Structural Modifications and Biological Activities of Berberine: An Active Compound in Traditional Chinese Medicine
Mini-Reviews in Medicinal Chemistry Perspectives on the Tertiary Prevention Strategy for Alzheimer’s Disease
Current Alzheimer Research Early Life and Oxidative Stress in Psychiatric Disorders: What Can we Learn From Animal Models?
Current Pharmaceutical Design Old Friends in New Constellations - the Hematopoetic Growth Factors G-CSF, GMCSF, and EPO for the Treatment of Neurological Diseases
Current Medicinal Chemistry Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers
Current Psychiatry Reviews Molecular Cytogenetics and Cytogenomics of Brain Diseases
Current Genomics The Heterogeneity of Amyotrophic Lateral Sclerosis: A Possible Explanation of Treatment Failure
Current Medicinal Chemistry A Role for TGF-β Signaling in Neurodegeneration: Evidence from Genetically Engineered Models
Current Alzheimer Research Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
Anti-Cancer Agents in Medicinal Chemistry Conformational Diseases: Structural Studies of Aggregation of Polyglutamine Proteins
Current Computer-Aided Drug Design Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases
Current Pharmacogenomics and Personalized Medicine Commentary: Histaminergic Drugs Could be Novel Targets for Neuroprotection in CNS Disorders
CNS & Neurological Disorders - Drug Targets Is Amyloid Binding Alcohol Dehydrogenase a Drug Target for Treating Alzheimer’s Disease?
Current Alzheimer Research 5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment
Current Topics in Medicinal Chemistry Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery The Role of 5-Hydroxymethylcytosine in Aging and Alzheimer’s Disease: Current Status and Prospects for Future Studies
Current Alzheimer Research